Lilly Expands Affordability With Lower-Priced Versions of Popular Insulin

Eli Lilly today announced plans to add two more cost-saving options to its suite of solutions for people who use Lilly insulin. The company plans to …

Bigfoot Biomedical Gets $45M Financing, will Support Completion of Unity™ Program

Bigfoot Biomedical, a medical device company creating insulin delivery through the use of AI and automation announced it has raised $45 million in …

Harvard: 5 Healthy Habits at Middle Age May Have Lasting Benefits

Maintaining five healthy habits–eating a healthy diet, exercising regularly, keeping a healthy body weight, not drinking too much alcohol, and …

A “Smart” Contact Lens May One Day Diagnosis Diabetes; Treat Retinopathy

A research team from a private research university in Pohang, South Korea, has developed technology that allows diagnosis of diabetes and treatment …

Health Company Aiming to Combat the Diabetes Epidemic Raises $93M

Virta Health, a company on a mission to reverse Type 2 diabetes, today announced that it has raised $93 million in Series C funding to combat the …

New Year’s Resolutions and Diabetes: 4 Steps to Setting Attainable Goals

By: Laurie Block, MS, RDN, CDE. Edited by: Suvarna Sheth. When it comes to making New Year’s resolutions it’s important to realize that change is …

Small UBC Study Finds Ketone Drink May Help Control Blood Sugar

With more people with diabetes and pre-diabetes looking for strategies to help control blood sugar, new research from the University of British …

Simple Steps to Dealing with a New Type 2 Diabetes Diagnosis

By: Susan Watkins, RDN, CDE It can be extremely overwhelming when you receive a new medical diagnosis of any kind, especially diabetes. You often get …

Novo Nordisk’s Launches New Insulin Affordability Offerings in the U.S.

Novo Nordisk launched a handful of new insulin affordability offerings for people living in the U.S. The new offerings include: My$99Insulin: …

FDA Approves Novo Nordisk’s Fiasp® for Children with Diabetes

The U.S. Food and Drug Administration (FDA) has approved Novo Nordisk’s Fiasp® (insulin aspart injection) 100 u/mL for use as a new mealtime …